AMD vs CBRS: Which Is the Better Buy in 2026?
Last updated August 2026
Short answer
AMD and CBRS are similarly sized, but AMD trades noticeably cheaper on forward earnings (34.45x vs 206.72x): the market is paying up for CBRS's profile and pricing AMD more conservatively, or for faster growth. Which you prefer comes down to the drivers you believe, and whether adding either over-concentrates what you already own.
AMD vs CBRS: the tie-breaker metrics
Same yardstick, side by side (as of August 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.
| Metric | AMD | CBRS | What it tells you |
|---|---|---|---|
| Forward P/E | 34.45 | 206.72 | Valuation on next year's expected earnings, the same yardstick for both. Lower is cheaper for that growth; higher means the market is paying up. |
| Trailing P/E | 158.72 | 431.98 | Valuation on the last 12 months. A big drop from trailing to forward means the market expects earnings to jump, so more growth is already in the price. |
| Price vs 52-week range | 75% of range | 17% of range | Where today's price sits between the 52-week low and high. Near the high is momentum with less margin of safety; near the low is out of favor or a discount, depending on why. |
Reading it: AMD is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.
Before you buy: how AMD and CBRS affect your concentration
The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. AMD and CBRS share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.
This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined AMD and CBRS exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.
What does Advanced Micro Devices (AMD) do?
Advanced Micro Devices (AMD) designs CPUs, GPUs, and adaptive computing chips. The company has two main client-facing CPU lines: Ryzen for consumer PCs and EPYC for data center servers. EPYC has gained significant share against Intel Xeon in cloud and enterprise data centers over the past five years. The Instinct GPU line (MI300X, MI325X, MI350, MI400) is AMD's AI accelerator platform and the primary direct competitor to NVIDIA's data center GPUs.
What does Cerebras Systems (CBRS) do?
Cerebras Systems (NASDAQ: CBRS) designs AI compute systems built around its Wafer-Scale Engine (WSE), a single chip the size of an entire silicon wafer with roughly 900,000 cores and large on-chip memory. That design keeps whole models in fast on-chip SRAM instead of shuttling weights to and from external memory, which lets Cerebras post very high token-generation speeds for AI inference. The company sells both on-premise systems and cloud inference capacity, positioning itself against Nvidia GPUs for large-model inference and AI supercomputing workloads. Founded in 2015 and based in Sunnyvale, California, it went public in May 2026 in one of the largest semiconductor IPOs on record.
AMD vs CBRS: how do they differ?
Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.
- AMD drivers: Instinct AI GPU ramp; EPYC server share gains.
- CBRS drivers: Inference speed leadership; OpenAI and backlog conversion.
Which fits which kind of investor
A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: NVIDIA's structural advantages in AI (CUDA ecosystem, manufacturing capacity allocations from TSMC, customer relationships) make AI GPU share gains harder than the hardware comparison alone suggests. For CBRS, customer concentration is the defining risk: roughly 86 percent of 2025 revenue came from two UAE-affiliated buyers, and much of the future backlog now depends on a single OpenAI agreement, so the loss or renegotiation of one relationship could sharply reduce revenue.
AMD or CBRS: which should you pick?
AMD vs CBRS: the full fundamentals
AMD. AMD trades at a premium P/E reflecting the AI accelerator growth story and EPYC share gains. The valuation depends on continued execution against NVIDIA in AI; multiple compresses quickly if Instinct share gains stall.
CBRS. Cerebras trades at a very high multiple of trailing revenue, reflecting expectations that its roughly $25 billion backlog, most tied to OpenAI, converts into rapid future revenue. Reported 2025 GAAP net income was inflated by a one-time non-cash gain from extinguishing a G42-related liability; on an adjusted basis the company still ran an operating loss. Investors are effectively pricing execution years ahead of current fundamentals.
Headline figures (approximate, early 2026): AMD shows revenue (ttm) ~$30 billion, operating margin ~25% (improving as data center mix grows), net income (ttm) ~$4 billion (GAAP; higher non-GAAP), eps (ttm) ~$2.50; CBRS shows revenue (fy2025) ~$510M, revenue growth (fy2025) ~76%, revenue (q1 2026 core) ~$191M, backlog / rpo ~$25B.
The bottom line: AMD vs CBRS
AMD and CBRS are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined AMD and CBRS exposure against your real portfolio. It is not an investment adviser.
Wondering how AMD or CBRS fits the portfolio you already own? Walnut is an AI investing app that connects your brokerage read-only and answers questions like that about your actual holdings: overlap, concentration, and how each position tracks the S&P 500. Compare the best AI portfolio analyzers or see the best AI investing apps in 2026.
Investing in Advanced Micro Devices with AI
Connect the broker you already use and ask Walnut's AI how AMD fits what you actually hold: whether you own it already through a fund, what it would do to your concentration, and how it has tracked the S&P 500. Read-only by default, and you approve anything before it reaches your broker.
FAQ
What is the difference between AMD and CBRS?
+
Advanced Micro Devices (AMD) designs CPUs, GPUs, and adaptive computing chips. Cerebras Systems (NASDAQ: CBRS) designs AI compute systems built around its Wafer-Scale Engine (WSE), a single chip the size of an entire silicon wafer with roughly 900,000 cores and large on-chip memory. They show up together because they share investment themes, but they are different businesses, so the better fit depends on which thesis you are expressing.
Is AMD or CBRS the better stock?
+
Neither is universally better; they suit different views and risk levels. Walnut is informational, not investment advice. Compare what each does, the tie-breaker metrics above, and the risks, then decide which fits your thesis and what you already own.
Which is cheaper, AMD or CBRS?
+
On forward P/E (as of August 2026), AMD trades at 34.45x and CBRS at 206.72x, so AMD is the cheaper of the two on next year's expected earnings. A lower multiple is not automatically the better buy: a richer valuation can be justified by faster growth, and a lower one can reflect real risk. Weigh the multiple against how fast each business is compounding.
Should you own both AMD and CBRS?
+
Because they share themes, owning both concentrates you in that theme. That can be intentional (a focused bet) or accidental (less diversification than it looks). Walnut can show your combined exposure across both, and whether adding either over-concentrates you, before you buy.
What are the risks of AMD vs CBRS?
+
AMD: NVIDIA's structural advantages in AI (CUDA ecosystem, manufacturing capacity allocations from TSMC, customer relationships) make AI GPU share gains harder than the hardware comparison alone suggests. Intel's eventual recovery in server CPUs is a multi-year risk. CBRS: Customer concentration is the defining risk: roughly 86 percent of 2025 revenue came from two UAE-affiliated buyers, and much of the future backlog now depends on a single OpenAI agreement, so the loss or renegotiation of one relationship could sharply reduce revenue. The valuation, a market capitalization near $51 billion on only a few hundred million dollars of trailing revenue, leaves little margin for execution stumbles or slower AI spending. Competition is intense, with Nvidia dominant and AMD, Groq, SambaNova, and in-house cloud silicon all pursuing inference. The stock is newly public and highly volatile (it has fallen sharply from its first-day highs), gross margins are modest, and 2025 GAAP profitability was inflated by a one-time non-cash gain rather than operating performance.
Related comparisons
Browse all stock comparisons.
Walnut is informational, not investment advice. This page is descriptive and not a recommendation to buy or sell AMD or CBRS; figures are approximate and dated (as of August 2026). Verify current data before investing.